Victoria Kutilek

Statistics

Publications

Citations

265

H-Index

Active since

2005

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Victoria Kutilek is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, ligand binding, and life sciences.

Publications per year

2005–2021

Publications

Identification of an allosteric binding site for RORγt inhibition

Marcel Scheepstra, S. Leysen, Geert C. van Almen et al. · Nature Communications · 2015 · 102 citations · Full text

Life Sciences, Immunology, Medicinal Chemistry +17

A mass spectrometry-based proteome map of drug action in lung cancer cell lines

Benjamin Ruprecht, Julie Di Bernardo, Zhao Wang et al. · Nature Chemical Biology · 2020 · 55 citations

Life Sciences, Biochemistry, Molecular Biology +16

Integration of Affinity Selection–Mass Spectrometry and Functional Cell-Based Assays to Rapidly Triage Druggable Target Space within the NF-κB Pathway

Victoria Kutilek, Christine L. Andrews, Matthew Richards et al. · SLAS DISCOVERY · 2016 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Identification of G-Quadruplex-Binding Inhibitors of Myc Expression through Affinity Selection–Mass Spectrometry

Deborah A. Flusberg, Noreen F. Rizvi, Victoria Kutilek et al. · SLAS DISCOVERY · 2018 · 28 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Discovery of <b>MK-4688</b> : an Efficient Inhibitor of the HDM2–p53 Protein–Protein Interaction

Michael H. Reutershan, Michelle R. Machacek, Michael D. Altman et al. · Journal of Medicinal Chemistry · 2021 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 6